These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39136879)

  • 1. The burden of hyperkalaemia on hospital healthcare resources.
    Logan Ellis H; Al-Agil M; Kelly PA; Teo J; Sharpe C; Whyte MB
    Clin Exp Med; 2024 Aug; 24(1):190. PubMed ID: 39136879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum potassium abnormalities in chronic kidney disease: prevalence, patient characteristics and clinical outcomes.
    Brookes EM; Snider J; Hart GK; Robbins R; Power DA
    Intern Med J; 2021 Nov; 51(11):1906-1918. PubMed ID: 33314585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.
    Gorriz JL; D'Marco L; Pastor-González A; Molina P; Gonzalez-Rico M; Puchades MJ; Sanchis I; Escudero V; Estañ N; de la Espriella R; Nuñez E; Pallardó L; Núñez J
    Nephrol Dial Transplant; 2022 Feb; 37(3):522-530. PubMed ID: 33508124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zhang L; Yao L; Shao G; Zuo L; Qin S; Zhang X; Zhang Q; Yu W; Luo Q; Ren Y; Peng H; Xiao J; Yang Q; Chen Q; Shi Y;
    BMC Nephrol; 2023 Aug; 24(1):233. PubMed ID: 37559023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method comparison study of a point-of-care blood gas analyser with a laboratory auto-analyser for the determination of potassium concentrations during hyperkalaemia in patients with kidney disease.
    Chothia MY; Kassum P; Zemlin A
    Biochem Med (Zagreb); 2020 Oct; 30(3):030702. PubMed ID: 32774124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).
    Boo AYY; Koh YLE; Hu PL; Tan NC
    BMJ Open; 2020 Sep; 10(9):e033755. PubMed ID: 32963061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.
    Maggioni AP; Dondi L; Andreotti F; Calabria S; Iacoviello M; Gorini M; Gonzini L; Piccinni C; Ronconi G; Martini N
    Eur J Clin Invest; 2021 Aug; 51(8):e13551. PubMed ID: 33786826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.
    Torres OH; Hernandez N; Francia E; Barcelo M; Mateo J; Ruiz D
    Drugs Aging; 2010 May; 27(5):399-406. PubMed ID: 20450237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalaemia in the emergency department: Epidemiology, management and monitoring of treatment outcomes.
    Pollack K; Manning KR; Balassone J; Bui C; Taylor DM; Taylor SE
    Emerg Med Australas; 2022 Oct; 34(5):751-757. PubMed ID: 35411698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term prognosis of changes in plasma potassium following an episode of hyperkalaemia in patients with chronic heart failure.
    Jønsson SS; Sørensen SA; Krøgh ST; Melgaard D; Søgaard P; Søndergaard MM; Leutscher P; Kragholm K; Aldahl M; Torp-Pedersen C; Krogager ML
    Eur J Intern Med; 2023 Dec; 118():82-88. PubMed ID: 37517938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patients.
    Park S; Baek SH; Lee SW; Lee A; Chin HJ; Na KY; Kim YS; Chae DW; Han JS; Kim S
    Sci Rep; 2017 May; 7(1):2402. PubMed ID: 28546546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients.
    Crop MJ; Hoorn EJ; Lindemans J; Zietse R
    Nephrol Dial Transplant; 2007 Dec; 22(12):3471-7. PubMed ID: 17848395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
    Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink.
    Furuland H; McEwan P; Evans M; Linde C; Ayoubkhani D; Bakhai A; Palaka E; Bennett H; Qin L
    BMC Nephrol; 2018 Aug; 19(1):211. PubMed ID: 30134846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict who will develop postoperative hyperkalaemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism?
    Song YH; Cai GY; Xiao YF; Wang YP; Yang ST; Chen XM
    BMC Nephrol; 2019 Jun; 20(1):225. PubMed ID: 31221111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
    Rajput J; Moore LSP; Mughal N; Hughes S
    Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care.
    Martín-Pérez M; Ruigómez A; Michel A; García Rodríguez LA
    BMC Fam Pract; 2016 May; 17():51. PubMed ID: 27145981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.